Showing results (181-190 of 288) with videos related to

Sort By:
Pageof 29
EULAR Rheumatology Open|June 29, 2026
Patients' perspectives of eosinophilic granulomatosis with polyangiitis within the context of a clinical trialPeter A Merkel, Bernhard Hellmich, Christian Pagnoux, et al.
Mayo Clinic Proceedings|September 20, 2021
Eosinophils in Health and Disease: A State-of-the-Art ReviewMichael E Wechsler, Ariel Munitz, Steven J Ackerman, et al.
The New England Journal of Medicine|September 9, 2024
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic PhenotypeDavid J Jackson, Michael E Wechsler, Daniel J Jackson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 17, 2021
Asthma Phenotyping in Primary Care: Applying the International Severe Asthma Registry Eosinophil Phenotype Algorithm Across All Asthma SeveritiesMarjan Kerkhof, Trung N Tran, Riyad Allehebi, et al.
The Journal of Allergy and Clinical Immunology|December 23, 2018
Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitisJonathan Steinfeld, Eric S Bradford, Judith Brown, et al.
The New England Journal of Medicine|October 27, 2021
Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe AsthmaMichael E Wechsler, Marcella K Ruddy, Ian D Pavord, et al.
The New England Journal of Medicine|May 18, 2017
Mepolizumab or Placebo for Eosinophilic Granulomatosis with PolyangiitisMichael E Wechsler, Praveen Akuthota, David Jayne, et al.
ERJ Open Research|March 11, 2026
Benralizumab reduces sputum ANCA in patients with eosinophilic granulomatosis with polyangiitisManali Mukherjee, Nadia Suray Tan, Chynna Huang, et al.
The Lancet. Respiratory Medicine|July 24, 2021
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trialKlaus F Rabe, Bartolome R Celli, Michael E Wechsler, et al.
The Journal of Allergy and Clinical Immunology|May 25, 2017
Income is an independent risk factor for worse asthma outcomesJuan Carlos Cardet, Margee Louisias, Tonya S King, et al.
Pageof 29